Clinical Trial Update: Efficacy and Safety Study of GerEPO [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of GerEPO for anemia associated with chronic kidney disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Chronic Kidney Disease

Drugs mentioned

• GerEPO (erythropoietin)

Snippet

Sponsor: Ministry of Health, Malaysia | Conditions: Chronic Renal Failure Related Anemia | Phase 3 | Status: COMPLETED